Shawn Rockey, PA
Physician Assistant · Rock Springs, WYNPI 1740682020
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 228 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 23.1% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in WY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 228 payments — averaging $18.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$982
- AbbVie$964
- Lilly USA, LLC$546
- GSK$315
- Novo Nordisk$281
- Amgen$204
- plus $953 from 25 others
What the payments were for
- Food & beverage$4,231100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 40 | $982 |
| AbbVie | 48 | $964 |
| Lilly USA, LLC | 40 | $546 |
| GSK | 20 | $315 |
| Novo Nordisk | 17 | $281 |
| Amgen | 9 | $204 |
| Grifols USA, LLC | 5 | $119 |
| Boehringer Ingelheim | 7 | $113 |
| Bayer | 5 | $80 |
| Merck | 4 | $70 |
| Viatris Specialty LLC | 4 | $68 |
| Pfizer | 4 | $62 |
| Argenx US, Inc. | 1 | $39 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $39 |
| Xeris Pharmaceuticals, Inc. | 2 | $38 |
| Exact Sciences | 2 | $37 |
| Vertex | 2 | $33 |
| Mylan Specialty L.p. | 2 | $32 |
| Verona Pharma, Inc. | 1 | $26 |
| Amarin Pharma, Inc. | 2 | $23 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Novartis | 1 | $20 |
| Boston Scientific | 1 | $19 |
| Sandoz | 1 | $18 |
| Sobi, Inc | 1 | $15 |
| Vistapharm, Inc. | 1 | $15 |
| Biogen | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Eisai Inc. | 1 | $14 |
| Medtronic | 1 | $13 |
| Astellas Pharma US Inc | 1 | $12 |
How this compares
$4,245 in reported general payments places this provider in the 95th percentile of 203 physician assistant providers in Wyoming.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 91 | $92,834 |
| EliquisApixaban | 74 | $68,793 |
| OzempicSemaglutide | 34 | $44,251 |
| TrulicityDulaglutide | 35 | $42,691 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 41 | $35,449 |
| XareltoRivaroxaban | 17 | $27,327 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 17 | $20,973 |
| JardianceEmpagliflozin | 13 | $20,780 |
| RybelsusSemaglutide | 18 | $20,004 |
| JanumetSitagliptin Phos/Metformin Hcl | 22 | $18,829 |
| Tresiba Flextouch U-200Insulin Degludec | 13 | $14,871 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $12,939 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $12,610 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 13 | $8,808 |
| Xtampza ErOxycodone Myristate | 11 | $7,979 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere, Bevespi Aerosphere | $982 | $137,091145 claims |
| PfizerEliquis | $62 | $68,79374 claims |
| Novo NordiskOzempic, Rybelsus | $281 | $64,25552 claims |
| Lilly USA, LLCTrulicity | $546 | $42,69135 claims |
| MerckJanumet Xr, Janumet | $70 | $39,80139 claims |
| Boehringer IngelheimJardiance | $113 | $20,78013 claims |
| GSKTrelegy Ellipta, Incruse Ellipta | $315 | $19,13223 claims |
| AbbVieSynthroid | $964 | $2,36935 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 203 physician assistant providers in Wyoming.
Other physician assistant in Rock Springs
- Brian BartonRock Springs$2K
- Tracy SeelRock Springs$700
- Tanja SloanSheridan$6K
- Joann RamseyCasper$5K
- Laurie JohnsonCasper$4K
- Robyn MorrisonCasper$4K
- Chloe LowneyAfton$4K
- Jennifer GraslieSheridan$4K
- Alison WatkinsCheyenne$3K
- Lacey MartinCasper$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.